{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:12:53Z","timestamp":1780513973058,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.jaad.2008.03.009","type":"journal-article","created":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T09:14:21Z","timestamp":1208250861000},"page":"125-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Drug-induced morphea: Report of a case induced by balicatib and review of the literature"],"prefix":"10.1016","volume":"59","author":[{"given":"Anna","family":"Peroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Zini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Colato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2008.03.009_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/0961203306070000","article-title":"Drug-induced lupus: an update","volume":"15","author":"Vasoo","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2008.03.009_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-4615-4857-7_27","article-title":"Dermatomyositis and drugs","volume":"455","author":"Dourmishev","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaad.2008.03.009_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0738-081X(98)00006-6","article-title":"Drug-induced scleroderma and sclerodermiform conditions","volume":"16","author":"Haustein","year":"1998","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2008.03.009_bib4","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1345\/aph.1K295","article-title":"Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis","volume":"41","author":"Peak","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2008.03.009_bib5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1046\/j.1365-2133.2000.03886.x","article-title":"Analysis of dendritic cell populations using a revised histological staging of morphea","volume":"143","author":"Gilmour","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.03.009_bib6","first-page":"108","article-title":"Morphea after beta-blocker therapy","volume":"3","author":"De Dobbeler","year":"1993","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2008.03.009_bib7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archderm.1973.01620190029007","article-title":"Cutaneous toxicity of bleomycin therapy","volume":"107","author":"Cohen","year":"1973","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.03.009_bib8","first-page":"10","article-title":"Symptomatische Sklerodermie durch bleomyzin","volume":"34","author":"Bork","year":"1983","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaad.2008.03.009_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3346\/jkms.1996.11.5.454","article-title":"A case of bleomycin-induced scleroderma","volume":"11","author":"Kim","year":"1996","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jaad.2008.03.009_bib10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1365-2133.2004.05969.x","article-title":"A case of peplomycin-induced scleroderma","volume":"150","author":"Asano","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.03.009_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/ard.40.1.42","article-title":"Morphea-like reaction to D-penicillamine therapy","volume":"40","author":"Bernstein","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2008.03.009_bib12","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/ard.48.11.963","article-title":"Development of morphoea in rheumatoid arthritis treated with penicillamine","volume":"48","author":"Liddle","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2008.03.009_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-4362.1989.tb02457.x","article-title":"Morphea after bromocriptine therapy","volume":"28","author":"Leshin","year":"1989","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2008.03.009_bib14","first-page":"691","article-title":"Syndrome scl\u00e9rodermiforme et po\u00efkilodermique observ\u00e9 au cours d'un traitement par carbidopa et 5-hydroxy-tryptophanne","volume":"112","author":"Auffranc","year":"1985","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2008.03.009_bib15","first-page":"209","article-title":"Syndrome scl\u00e9rodermiforme \u00e0 type de morph\u00e9es bulleuses au cours d'un traitement par 5-hydroxy-tryptophane, carbidopa et flunitrazepam","volume":"119","author":"Lampert","year":"1992","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2008.03.009_bib16","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archderm.1996.03890350111019","article-title":"Localized indurated brown plaques on arms and right buttock","volume":"132","author":"Bellman","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.03.009_bib17","first-page":"1252","article-title":"Vitamin B12-associated localized scleroderma and its treatment","volume":"30","author":"Ho","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2008.03.009_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0536.1994.tb01905.x","article-title":"Sclerodermatous skin reaction after vitamin K1 injections","volume":"31","author":"Giudetti","year":"1994","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2008.03.009_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-4362.1995.tb01569.x","article-title":"Morphea-like reaction from vitamin K1","volume":"34","author":"Morell","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2008.03.009_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0190-9622(98)70574-2","article-title":"Vitamin K1-induced localized scleroderma (morphea) with linear deposition of IgA in the basement membrane zone","volume":"38","author":"Alonso-Llamazares","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.03.009_bib21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.clinthera.2006.08.004","article-title":"A review of the receptor-binding and pharmacokinetic properties of dopamine agonists","volume":"28","author":"Kvernmo","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2008.03.009_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/138161207779313542","article-title":"Emerging roles of cysteine cathepsins in disease and their potential as drug targets","volume":"13","author":"Vasiljeva","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jaad.2008.03.009_bib23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.addr.2004.12.013","article-title":"The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics","volume":"57","author":"Yasuda","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jaad.2008.03.009_bib24","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1021\/cr0101656","article-title":"Human and parasitic papain-like cysteine proteases : their role in physiology and pathology and recent developments in inhibitor design","volume":"102","author":"Lecaille","year":"2002","journal-title":"Chem Rev"},{"key":"10.1016\/j.jaad.2008.03.009_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.0959-9673.2004.00373.x","article-title":"Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy","volume":"85","author":"Potts","year":"2004","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.jaad.2008.03.009_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.jid.5700535","article-title":"Role of cathepsin K in the turnover of the dermal extracellular matrix during scar formation","volume":"127","author":"R\u00fcnger","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2008.03.009_bib27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S8756-3282(00)00445-2","article-title":"Biosynthesis and processing of cathepsin K in cultured human osteoclasts","volume":"28","author":"Rieman","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.jaad.2008.03.009_bib28","doi-asserted-by":"crossref","first-page":"12517","DOI":"10.1074\/jbc.271.21.12517","article-title":"Proteolytic activity of human osteoclasts cathepsin K","volume":"271","author":"Bossard","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2008.03.009_bib29","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2174\/156802605775009676","article-title":"Design of cathepsin K inhibitors for osteoporosis","volume":"5","author":"Deaton","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jaad.2008.03.009_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/mol.107.039511","article-title":"Effect of cathepsin k inhibitor basicity on in vivo off-target activities","volume":"73","author":"Desmarais","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaad.2008.03.009_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cbf.290090109","article-title":"Study of thiol proteases of normal human skin fibroblasts","volume":"9","author":"Khalfan","year":"1991","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.jaad.2008.03.009_bib32","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0002-9440(10)63777-7","article-title":"Pivotal role of cathepsin K in lung fibrosis","volume":"164","author":"B\u00fchling","year":"2004","journal-title":"Am J Pathol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208002971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208002971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:10:04Z","timestamp":1759270204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962208002971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0190962208002971"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2008.03.009","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced morphea: Report of a case induced by balicatib and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2008.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}